Biotech Firms
- None, Law360
As seen in:
Law360,
Digital Journal,
EIN News,
MENAFN,
EIN Presswire,
Global information inc,
Prophecy Market Insights
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Biotech Firms
Transfection Reagents And Equipment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)
According to Mordor Intelligence, the transfection reagents and equipment market size was valued at USD 1.26 billion in 2025 and estimated to grow from USD 1.34 billion in 2026 to reach USD 1.81 billion by 2031, at a CAGR of 6.24% during the forecast period (2026-2031).
Transfection Reagents And Equipment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
The transfection reagents and equipment market size reached USD 1.26 billion in 2025 and is forecast to advance to USD 1.71 billion by 2030, reflecting a 6.30% CAGR. This steady expansion is propelled by regulatory momentum in cell and gene therapies, sustained R&D spending by pharmaceutical manufacturers, and rapid method-level innovation that improves scalability for commercial production.
Next Generation Sequencing Market Valued at US$ 49,279.9 Million by 2030 with CAGR of 18.3% Report by Coherent Market Insights
Coherent Market Insights published the latest research report, titled “Next Generation Sequencing Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2030,” provides a thorough analysis of the market dynamics, segmentation, growth opportunities, trends, and competitive landscape to comprehend the present and foreseeable market conditions.
Next Generation Sequencing Market is Projected to increase at a CAGR of around 18.3% during 2023 to 2030: Illumina, Inc.
Next Generation Sequencing Market Analysis BURLINGAME, CALIFORNIA, UNITED STATES, April 24, 2023 /EINPresswire.com/ -- Next Generation Sequencing Market is a high-throughput DNA sequencing technique that revolutionized genomic research by providing rapid and cost-effective access to large amounts of DNA sequence data.
Next-Generation Sequencing (NGS) Market Size, Growth Report 2034
What's Covered in Full Report Market Size & Share Analysis Market Trends Analysis Market Players Analysis Define Business Strategies Import & Export Data Growth Driving Factors Future Commercial Potential Regional & Country Wise Growth Insights Looks good! Please enter your full name. Looks good! Please provide a valid email address. Looks good! Please select a country. Looks good! Please enter your contact number. Looks good! Please enter your company name. * These fields are required.
SEC Aims To 'Slam The Courthouse Door,' Tilton Tells Justices
Law360, New York (May 10, 2017, 3:57 PM EDT) -- Private equity magnate Lynn Tilton has again pressed the U.S. Supreme Court to weigh the constitutionality of the U.S. Securities and Exchange Commission’s administrative law judges, arguing that she should not have to wait for the agency’s proceedings against her to finish before she can challenge their legitimacy.
How CHOICE Act May Change SEC Reporting, Corp. Governance
Law360, New York (May 10, 2017, 11:25 AM EDT) -- The House Financial Services Committee recently approved an updated version of the Financial CHOICE Act, a bill designed to reverse many features of the landmark Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010. Commonly referred to as the “CHOICE Act 2.0,” this bill is the second version of a reform bill that was introduced last year by committee Chairman Jeb Hensarling, R-Texas.
SEC, Chinese Investors' Atty Spar Over EB-5 'Securities'
Law360, Los Angeles (May 9, 2017, 9:21 PM EDT) -- The U.S. Securities and Exchange Commission and a New York immigration attorney accused of violating broker-dealer rules each urged a California federal judge on Tuesday to decide whether EB-5 investments are securities subject to broker-dealer rules and resolve their respective bids for quick wins in the agency's suit.
SEC's Piwowar Warns 'SAFE' Investments Carry Risks
Law360, New York (May 9, 2017, 6:38 PM EDT) -- U.S. Securities and Exchange Commission member Michael Piwowar on Tuesday urged investors to be wary of the pitfalls of so-called SAFE investments — a sophisticated financing instrument for startup companies — that are increasingly being marketed to the broader retail investing public.
Simpson Thacher Deal Maker Picked To Lead SEC Corp. Unit
Law360, New York (May 9, 2017, 6:33 PM EDT) -- U.S. Securities and Exchange Commission Chairman Jay Clayton has selected a recently retired Simpson Thacher & Bartlett LLP attorney who worked alongside him on the record-breaking Alibaba IPO to head the agency’s Division of Corporation Finance, the SEC said Tuesday. Former Simpson Thacher partner William H.
US Report Finds 'Little Interest' In China Finance Markets
Law360, Washington (May 9, 2017, 6:22 PM EDT) -- The U.S. economic risks posed by a slowing Chinese economy and its financial sector don't come from direct links, thanks to "little interest" by American investors, but from "indirect channels," according to a staff report Tuesday from a commission charged with monitoring relations between China and the United States.
Contura Energy Marks Latest Coal Co. To Seek IPO
Law360, New York (May 9, 2017, 6:20 PM EDT) -- Coal producer Contura Energy Inc., formed out of Alpha Natural Resources Inc.’s bankruptcy restructuring, filed initial public offering plans on Monday, marking the third coal company to pursue an IPO this year amid improving market conditions and expectations of a friendlier regulatory environment.
UBS Says It Didn't Know Judge's Dad Had Arbitration 'Cameo'
Law360, New York (May 9, 2017, 5:07 PM EDT) -- UBS Financial Services Inc. on Monday responded to a Puerto Rican judge's criticism regarding its failure to discover his father’s "cameo" in a hearing related to a financial institution's unsuccessful $70 million arbitration bid, saying its local counsel did not think it had to report his father's involvement. U.S. District Judge Gustavo A.
3 Cos. Launch IPOs Totaling $300M Led By Biotech Firms
Law360, New York (May 8, 2017, 3:20 PM EDT) -- Two cancer-focused biotech companies set terms on initial public offerings Monday totaling $165 million, following Friday's launch of an expected $135 million offering from China's largest operator of bilingual schools, marking the latest batch of offerings to join a revived IPO market.
Korean Law Applies To $73M Citi Fraud Suit, 2nd Circ. Told
Law360, New York (May 9, 2017, 5:33 PM EDT) -- South Korean circuit board maker Simmtech Co. Ltd. asked the Second Circuit to reinstate the company's $73 million currency-exchange fraud suit against Citibank NA, arguing Tuesday that the lower court should have used Korean law when determining preclusion.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Biotech
Contact Biotech, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack